519 related articles for article (PubMed ID: 29480637)
41. [Oral bisphosphonates, denosumab and osteonecrosis of the jaws].
Cardona Tortajada F; Sainz Gómez E; Viñal Lozano D
Aten Primaria; 2015 May; 47(5):319-20. PubMed ID: 25523928
[No Abstract] [Full Text] [Related]
42. Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients.
Kemp APT; Ferreira VHC; Mobile RZ; Brandão TB; Sassi LM; Zarpellon A; Braz-Silva PH; Schussel JL
Braz J Otorhinolaryngol; 2022; 88(5):683-690. PubMed ID: 33189595
[TBL] [Abstract][Full Text] [Related]
43. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
[TBL] [Abstract][Full Text] [Related]
44. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T
J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295
[TBL] [Abstract][Full Text] [Related]
45. Antiresorptive Therapies for Osteoporosis.
Weinerman S; Usera GL
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):555-60. PubMed ID: 26412797
[TBL] [Abstract][Full Text] [Related]
46. Etiopathogenesis of medication-related osteonecrosis of the jaws: a review.
Bassan Marinho Maciel G; Marinho Maciel R; Linhares Ferrazzo K; Cademartori Danesi C
J Mol Med (Berl); 2024 Mar; 102(3):353-364. PubMed ID: 38302741
[TBL] [Abstract][Full Text] [Related]
47. What is the Risk of Developing Osteonecrosis Following Dental Extractions for Patients on Denosumab for Osteoporosis?
Colella A; Yu E; Sambrook P; Hughes T; Goss A
J Oral Maxillofac Surg; 2023 Feb; 81(2):232-237. PubMed ID: 36442534
[TBL] [Abstract][Full Text] [Related]
48. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
[TBL] [Abstract][Full Text] [Related]
49. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
50. Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw.
Kim HY
Endocrinol Metab (Seoul); 2021 Oct; 36(5):917-927. PubMed ID: 34674506
[TBL] [Abstract][Full Text] [Related]
51. Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review.
Querrer R; Ferrare N; Melo N; Stefani CM; Dos Reis PED; Mesquita CRM; Borges GA; Leite AF; Figueiredo PT
Support Care Cancer; 2021 Jun; 29(6):2811-2820. PubMed ID: 33140246
[TBL] [Abstract][Full Text] [Related]
52. [Progress on medication-related osteonecrosis of the jaw].
Wang QZ; Liu JY; Pan J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):568-572. PubMed ID: 30465354
[TBL] [Abstract][Full Text] [Related]
53. A current update on osteonecrosis of the jaw and bisphosphonates.
Arrain Y; Masud T
Dent Update; 2011 Dec; 38(10):672-6, 678. PubMed ID: 22408887
[TBL] [Abstract][Full Text] [Related]
54. Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?
Kuroshima S; Kaku M; Matsuura T; Atsuta I; Ayukawa Y; Sawase T
J Prosthodont Res; 2016 Oct; 60(4):229-230. PubMed ID: 26874926
[No Abstract] [Full Text] [Related]
55. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
[TBL] [Abstract][Full Text] [Related]
56. Management of antiresorptive osteonecrosis of the jaws with primary surgical resection.
Carlson ER
J Oral Maxillofac Surg; 2014 Apr; 72(4):655-7. PubMed ID: 24480762
[No Abstract] [Full Text] [Related]
57. Re: Management of antiresorptive osteonecrosis of the jaws with primary surgical resection.
Schwartz HC; O'Ryan FS
J Oral Maxillofac Surg; 2014 Sep; 72(9):1641. PubMed ID: 25109577
[No Abstract] [Full Text] [Related]
58. Antiresorptives and osteonecrosis of the jaw.
Yamashita J; McCauley LK
J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
[TBL] [Abstract][Full Text] [Related]
59. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
Janovska Z; Mottl R; Slezak R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
[TBL] [Abstract][Full Text] [Related]
60. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
